Abstract:Shiyang Wang, 1, 2 Tianlong Wang, 1 Li Wang, 1 Liansheng Zhong, 3 Kai Li 2 1 Department of Geriatric Surgery, The First Hospital, China Medical University, Shenyang 110001, People's Republic of China; 2 Department of Surgical Oncology, The First Hospital, China Medical University, Shenyang 110001, People's Republic of China; 3 Department of Bioinformatics, College of Life Science, China Medical University, Shenyang 110001, People's Republic of China Correspondence: Kai Li Department of Surgical Oncology, The First Hospital, China Medical University, Shenyang 110001, People's Republic of China Tel +86-13998245233 Email cmu_likai@163.com Background: RING finger protein 126 (RNF126), as a novel E3 ubiquitin ligase, plays an oncogenic role in several solid cancers. But its potential role in colorectal cancer (CRC) that harbored 50% mutant p53, to our knowledge, is rarely reported. Materials and Methods: We investigated the clinical significance and relationship of RNF126 and p53 in CRC tissues and cells. Meanwhile, WB, qRT-PCR, co-IP, MTT, and transwell were used to investigate the function and molecular mechanism of RNF126 in regulating malignant biology in vitro. Results: RNF126 was overexpressed in human CRC specimens, which was tightly associated with tumor size ( P =0.021), T stage ( P =0.030), lymph node metastasis ( P =0.006), TNM stage ( P =0.001), and the poor survival ( P =0.003) of CRC patients. RNF126 had no association with p53 mutation in CRC specimens, and in p53 mutant Colo-205 and SW620 cells. However, in p53 wildtype HCT116 and HCT-8 cells, RNF126 silencing upregulated p53 and p21 but inhibited Rb phosphorylation at Serine 780 (pRb), which was inhibited by p53siRNA. Conversely, RNF126 overexpression downregulated p53 and p21 but promoted pRb expression, which was reversed by a classic proteasome inhibitor, MG132. However, the mRNA levels of above target genes were unchanged, implying a ubiquitination dependent post-translational modification involving in above regulation. Meanwhile, RNF126 was co-immunoprecipitated with p53 and p21 to form a triple complex. RNF126 silencing and overexpression inhibited and promoted p53 ubiquitination and degradation in vitro, respectively. In addition, p53siRNA reversed RNF126 silencing-inhibited cell proliferation, drug resistance, and cell mobility in HCT116 cells. Conversely, MG132 inhibited RNF126 overexpression-promoted above cell biology in HCT-8 cells. Conclusion: Overexpression of RNF126 was remarkably associated with multiple advanced clinical characters of CRC patients independent of mutant p53. RNF126 promotes cell proliferation, mobility, and drug resistance in CRC via enhancing p53 ubiquitination and degradation. Keywords: RING finger protein 126, p53, ubiquitination, colorectal cancer

RNF125&nbsp;Modulates Tumor Immunity by Promoting Ubiquitination of PD-L1

Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation

The E3 Ligase Ring1 Targets P53 For Degradation And Promotes Cancer Cell Proliferation And Survival

RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway

RNF43 in cancer: Molecular understanding and clinical significance in immunotherapy

Pathological significance of abnormal recepteur d'origine nantais and programmed death ligand 1 expression in colorectal cancer

Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187

RNF141 interacts with KRAS to promote colorectal cancer progression

RNF126 contributes to stem cell-like properties and metastasis in hepatocellular carcinoma through ubiquitination and degradation of LKB1

Overexpression of RNF126 Promotes the Development of Colorectal Cancer via Enhancing p53 Ubiquitination and Degradation

The role and mechanism of action of RNF186 in colorectal cancer through negative regulation of NF-κB

RNF183 promotes proliferation and metastasis of colorectal cancer cells via activation of NF- κ B-IL-8 axis

Systematic Pan-Cancer Analysis of RNF186 with Potential Implications in Progression and Prognosis in Human Cancer.

Ring finger protein 128 promotes, rather than inhibits, colorectal cancer progression by regulating the Hippo signaling pathway

Ring Finger Protein 31–mediated Atypical Ubiquitination Stabilizes Forkhead Box P3 and Thereby Stimulates Regulatory T-cell Function

RNF115 aggravates tumor progression through regulation of CDK10 degradation in thyroid carcinoma

Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation

A Pan-Cancer Analysis of Ring Finger Protein 135 and Its Relationship to Triple-Negative Breast Cancer Proliferation and Metastasis.

Overexpression of RNF38 Facilitates TGF-β Signaling by Ubiquitinating and Degrading AHNAK in Hepatocellular Carcinoma.

RIG-I promotes immune evasion of colon cancer by modulating PD-L1 ubiquitination

RNF125‐mediated ubiquitination of MCM6 regulates the proliferation of human liver hepatocellular carcinoma cells

RNF125&amp;nbsp;Modulates Tumor Immunity by Promoting Ubiquitination of PD-L1